ArticleFrontiers in oncology2023

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey.

Çağlar Ünal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.